Quantcast

Latest Clinical trial Stories

2014-05-16 08:26:14

SAN DIEGO, May 16, 2014 /PRNewswire/ -- GenomeDx Biosciences today announced the launch of the Decipher® Portal Professional, a mobile app designed for iPad tablets that allows registered medical practitioners to use and understand genomic information about prostate cancer and how it can impact their clinical practice. It offers physicians the opportunity to explore Decipher clinical data on interactive graphs, engage in hands-on exploration of clinical use scenarios and learn more...

2014-05-15 23:14:53

Collaboration Will Ensure Local Monitoring and Centralized Clinical Research Technology for Sponsors of Multinational Clinical Trials Irvine, CA (PRWEB) May 15, 2014 ClinDatrix, Inc. (http://www.clindatrix.com) has signed collaboration agreements with six contract research organizations (CROs) from around the world to form a consortium that offers services for multinational clinical trials. On joint projects, consortium members will provide clinical trial project management, clinical...

2014-05-15 16:27:35

TORONTO, May 15, 2014 /PRNewswire/ - Portage Biotech Inc. ("Portage") (OTCQB: PTGEF, Canadian Stock Exchange: PBT.U), is pleased to inform that its wholly owned subsidiary, Portage Pharmaceuticals Ltd.(PPL or the Company) has entered into a materials collaborative research and development agreement (M-CRADA) with the National Eye Institute, one of the National Institutes of Health. Portage will provide its lead cell permeable peptide targeting inflammatory diseases to Dr. Robert...

2014-05-15 12:33:31

CAESAREA, Israel, May 15, 2014 /PRNewswire/ -- Resources will be channeled towards randomized clinical studies and further commercialization. Keystone Heart will exhibit and present at EuroPCR next week in Paris. Keystone Heart, a medical device company and the developer of CE marked TriGuard(TM) Cerebral Protection Device [http://www.keystoneheart.com/products ], has successfully raised $14M in a series B round of financing led by OrbiMed. OrbiMed is a leading...

2014-05-15 08:33:06

Completes Enrollment in Phase 2b Clinical Trial of CLP-1001 for Heart Failure SUNNYVALE, Calif., May 15, 2014 /PRNewswire/ -- Sorbent Therapeutics, Inc., a biopharmaceutical company developing therapies for cardiovascular and renal diseases, today announced the closing a $6.5 million tranche in a $15 million Series D financing. Existing investors CMEA Capital, ARCH Venture Partners, Sofinnova Ventures, AgeChem and Novartis Venture Funds participated in the round. Sorbent also...

2014-05-15 08:31:10

TORONTO, May 15, 2014 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) today announced the dosing of the first patient in a Phase 2 clinical study of TT-401 (LY2944876), a drug candidate for the treatment of type 2 diabetes. The study is expected to enroll up to 375 type 2 diabetes subjects and will be performed by Transition's development partner, Eli Lilly and Company ("Lilly"). The objectives of the study will be to...

2014-05-14 08:32:29

iCTRS General Manager to Speak to 1,400 at 6th Annual DIA China Meeting PRINCETON, N.J., May 14, 2014 /PRNewswire/ -- inVentiv Clinical Trial Recruitment Solutions (iCTRS), created to accelerate trials, will speak to an expected audience of 1,400 people Wednesday on leveraging the digital ecosystem to speed clinical trial recruitment in China. Ramita Tandon, senior vice president and General Manager of iCTRS, will speak at the 6th Annual DIA China Meeting on "Enhancing Clinical...

2014-05-14 08:32:01

- Bayer HealthCare joins internet portal www.clinicalstudydatarequest.com LEVERKUSEN, Germany, May 14, 2014 /PRNewswire/ -- Bayer HealthCare announced today that it will start sharing data from its clinical studies through the internet portal www.clinicalstudydatarequest.com. From now on, qualified researchers can request anonymized patient-level data from Bayer HealthCare sponsored clinical studies listed on the website. http://photos.prnewswire.com/prnvar/20140312/NY79226LOGO...

2014-05-14 08:27:35

LONDON, May 14, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Retinoblastoma Global Clinical Trials Review, H1, 2014http://www.reportbuyer.com/pharma_healthcare/research_r_d/clinical_trials/retinoblastoma_global_clinical_trials_review_h1.htmlRetinoblastoma Global Clinical Trials Review, H1, 2014SummaryGlobalData's clinical trial report, "Retinoblastoma Global Clinical Trials Review, H1, 2014" provides data on the Retinoblastoma clinical trial scenario....

2014-05-13 23:16:06

Achieve is conducting a Phase 2b, vehicle-controlled, multi-center study of the efficacy and safety of a topically applied experimental gel in subjects with moderate to severe pain associated with osteoarthritis (OA) of the knee following cessation of pain therapy. Birmingham, AL (PRWEB) May 13, 2014 *To see if you qualify for this OA Clinical Trial in Birmingham, visit Achieve Clinical Research on the web (http://www.achieveclinical.com/) or contact us directly at (205) 380-6434. There...


Word of the Day
call-note
  • The call or cry of a bird or other animal to its mate or its young.
'Call-note' is newer than 'bird-call,' which originally referred to 'an instrument for imitating the note of birds' but now also refers to 'the song or cry of a bird.'
Related